# Notifying FDA of Fatalities Related to Blood Collection or Transfusion:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/notifying-fda-of-fatalities-related-to-blood-collection-or-transfusion-guidance-for-industry/00f8c605-19b4-4774-a558-04c89f70b1d1

> FDA guidance document: Notifying FDA of Fatalities Related to Blood Collection or Transfusion:  Guidance for Industry. Issue date: August 20, 2021. Get complete insights and analysis.

---

## Details

- Title: Notifying FDA of Fatalities Related to Blood Collection or Transfusion:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2021-08-20
- Last Changed: 2024-04-18
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2002-D-0010">FDA-2002-D-0010</a>

## Related Documents

- [Considerations for the Development of Dried Plasma Products Intended for Transfusion:   Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/considerations-for-the-development-of-dried-plasma-products-intended-for-transfusion-guidance-for-industry/c0c693ab-7392-4bad-b4c9-de122a24ced4)
- [Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/bacterial-risk-control-strategies-for-blood-collection-establishments-and-transfusion-services-to-enhance-the-safety-and-availability-of-platelets-for-transfusion-guidance-for-industry/333bd28f-2882-4660-b183-54b97fa26003)
- [Recommendations for Screening, Testing, and Management of Blood Donors and Blood and Blood Components Based on Screening Tests for Syphilis:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-for-screening-testing-and-management-of-blood-donors-and-blood-and-blood-components-based-on-screening-tests-for-syphilis-guidance-for-industry/55e82ed9-047c-4235-9442-7dc1d1a9a4d0)